Correction to: Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study
本文未提供摘要，请点击“查看全文”查看完整内容。